Laman UtamaTMCI • NASDAQ
Treace Medical Concepts Inc
$5.77
Selepas Waktu Dagangan:
$5.77
(0.00%)0.00
Tutup: 27 Sep, 5:20:00 PTG GMT-4 · USD · NASDAQ · Penafian
SahamSekuriti tersenarai AS
Tutup sebelumnya
$5.80
Julat hari
$5.74 - $6.07
Julat tahun
$3.92 - $15.98
Permodalan pasaran
318.41J USD
Bilangan Purata
582.34K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)Jun 2024Perubahan T/T
Hasil
44.46J5.96%
Perbelanjaan pengendalian
57.06J20.55%
Pendapatan bersih
-21.21J-72.81%
Margin untung bersih
-47.70-63.08%
Pendapatan bagi setiap syer
-0.28-41.25%
EBITDA
-19.27J-61.13%
Kadar cukai berkesan
Jumlah aset
Jumlah liabiliti
(USD)Jun 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
95.05J-31.86%
Jumlah aset
226.08J-9.44%
Jumlah liabiliti
113.94J14.30%
Jumlah ekuiti
112.14J
Syer tertunggak
62.19J
Harga kepada buku
3.22
Pulangan pada aset
-22.80%
Pulangan pada modal
-28.25%
Perubahan bersih dalam tunai
(USD)Jun 2024Perubahan T/T
Pendapatan bersih
-21.21J-72.81%
Tunai daripada operasi
-13.90J-66.73%
Tunai daripada pelaburan
22.43J315.23%
Tunai daripada pembiayaan
311.00K-73.64%
Perubahan bersih dalam tunai
8.85J150.33%
Aliran tunai bebas
-8.23J2.70%
Perihal
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Diasaskan
2014
Tapak web
Pekerja
516
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama